Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Net Income (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Net Income for 16 consecutive years, with $514000.0 as the latest value for Q2 2025.

  • Quarterly Net Income rose 204.9% to $514000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $514000.0 through Dec 2025, up 154.16% year-over-year, with the annual reading at $514000.0 for FY2025, 154.16% up from the prior year.
  • Net Income hit $514000.0 in Q2 2025 for Perspective Therapeutics, up from -$490000.0 in the prior quarter.
  • In the past five years, Net Income ranged from a high of $1.3 million in Q2 2021 to a low of -$5.2 million in Q4 2023.
  • Historically, Net Income has averaged -$1.5 million across 5 years, with a median of -$1.5 million in 2023.
  • Biggest five-year swings in Net Income: soared 213.3% in 2021 and later tumbled 254.38% in 2022.
  • Year by year, Net Income stood at -$1.6 million in 2021, then crashed by 41.83% to -$2.3 million in 2022, then tumbled by 127.82% to -$5.2 million in 2023, then soared by 90.55% to -$490000.0 in 2024, then surged by 204.9% to $514000.0 in 2025.
  • Business Quant data shows Net Income for CATX at $514000.0 in Q2 2025, -$490000.0 in Q2 2024, and -$459000.0 in Q1 2024.